Search

Learn why Black men should be especially mindful of prostate cancer risk.

… Friday, January 17, 2025 Cancer does not discriminate, except when it does.  Prostate cancer  takes a harsher toll on Black men than other American men. Black men are almost 70% more likely than white men to develop prostate cancer in their lifetime and twice as likely to die from the disease, according

Treating people with advanced metastatic kidney cancer using a combination of the immunotherapy drugs nivolumab (Opdivo®) and ipilimumab (Yervoy®) significantly increased overall survival versus treatment with sunitinib (Sutent®) alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) that were reported online today in the New England Journal of Medicine.

… Wednesday, March 21, 2018 Treating people with advanced metastatic kidney cancer using a combination of the immunotherapy drugs nivolumab (Opdivo ® ) and ipilimumab (Yervoy ® ) significantly increased overall survival versus treatment with sunitinib (Sutent ® ) alone, according to new findings from researchers

An FDA-approved drug used to treat leukemia can serve as a temporary off switch for CAR T cells, MSK scientists have found.

… Wednesday, July 3, 2019 Summary Researchers at Memorial Sloan Kettering and University Hospital in Würzburg, Germany, have identified a simple way to temporarily switch off CAR T cells with a commonly used drug. The approach could potentially help doctors limit the sometimes-severe side effects of this

According to a new study from Memorial Sloan Kettering published June 24 in Nature Medicine, patients in active cancer treatment who develop COVID-19 infection don’t fare any worse than other hospitalized patients. Researchers say their findings suggest that no one should delay cancer treatment because of concerns about the virus.

… Wednesday, June 24, 2020 Background Mini Kamboj, MD Mini Kamboj, MD Ying Taur, MD, PhD Ying Taur, MD, PhD The characterization of COVID-19 in patients with cancer remains limited in published studies and nationwide surveillance analyses. Reports from China and Italy have raised the possibility that patients

Read about a therapeutic vaccine that could potentially prevent certain pancreatic and colorectal cancers from returning.

… Monday, August 11, 2025 According to a study co-led by researchers at Memorial Sloan Kettering Cancer Center (MSK), a new vaccine shows encouraging early results as a potential “off-the-shelf” treatment for patients with  pancreatic  or  colorectal cancer . Unlike individualized cancer vaccines, which

Lea sobre una vacuna terapéutica que podría ayudar a prevenir que ciertos casos de cáncer de páncreas y colorrectal vuelvan a aparecer.

… Monday, August 11, 2025 Según un estudio codirigido por investigadores del Memorial Sloan Kettering Cancer Center (MSK), una nueva vacuna muestra resultados iniciales prometedores como posible tratamiento ‘listo para usar’ para pacientes con cáncer de páncreas  o  colorrectal . A diferencia de las vacunas

Oncologic outcomes are similar with the use of a sentinel lymph node algorithm compared to performing a full pelvic and paraaortic lymph node dissection in node-negative patients with deeply invasive endometroid endometrial carcinoma.

… Monday, January 14, 2019 Oncologic outcomes are similar with the use of a sentinel lymph node (SLN) algorithm compared to performing a full pelvic and paraaortic lymph node dissection (LND) in node-negative patients with deeply invasive endometroid endometrial carcinoma (EEC), according to our recent

… Wednesday, May 2, 2018 Summary This story originally appeared in Bridges, our newsletter for cancer survivors. Bridges offers a forum in which patients and their families can share stories of inspiration and hope, and of the challenges that can accompany a cancer journey. Learn more about how to receive

The SNO Lifetime Achievement Award is given annually to a meritorious individual who has made significant contributions in neuro-oncology over their career in clinical care and/or translational or basic research.

… Monday, November 20, 2023 Lisa DeAngelis, MD , Chief Physician Executive and Scott M. and Lisa G. Stuart Chair of Memorial Sloan Kettering Cancer Center (MSK), was awarded the prestigious  Society for Neuro-Oncology (SNO) 2023 Lifetime Achievement Award. The SNO Lifetime Achievement Award is given annually

With the creation of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering sets out to deliver on the promise of personalized medicine by creating better treatment options for all people with cancer.

… Tuesday, May 20, 2014 Summary With the creation of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering sets out to deliver on the promise of personalized medicine by creating better treatment options for all people with cancer. We are thrilled to announce the creation